Last reviewed · How we verify

Progesterone Suppositories Vaginal

Assiut University · FDA-approved active Small molecule Quality 5/100

Progesterone Suppositories Vaginal is a Small molecule drug developed by Assiut University. It is currently FDA-approved. Also known as: Prontogest.

At a glance

Generic nameProgesterone Suppositories Vaginal
Also known asProntogest
SponsorAssiut University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Progesterone Suppositories Vaginal

What is Progesterone Suppositories Vaginal?

Progesterone Suppositories Vaginal is a Small molecule drug developed by Assiut University.

Who makes Progesterone Suppositories Vaginal?

Progesterone Suppositories Vaginal is developed and marketed by Assiut University (see full Assiut University pipeline at /company/assiut-university).

Is Progesterone Suppositories Vaginal also known as anything else?

Progesterone Suppositories Vaginal is also known as Prontogest.

What development phase is Progesterone Suppositories Vaginal in?

Progesterone Suppositories Vaginal is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing